Vertigo News and Research

Latest Vertigo News and Research

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma Inc. and Medivation, Inc. today announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or metastatic castration-resistant prostate cancer.

2 Apr 2015

23andMe announces publication of genome-wide association study of motion sickness

23andMe, Inc., the leading personal genetics company, today announced the publication of the first ever genome-wide association study of motion sickness.

4 Feb 2015

Whole exome sequencing helps Mayo Clinic neurologist solve a medical mystery

Precision medicine is getting a jump-start from a new national initiative announced in President Obama's State of the Union message. One Georgia family has already experienced its benefits: genomic testing called whole exome sequencing helped Mayo Clinic neurologist Zbigniew Wszolek, M.D., solve a medical mystery that had left a boy with painful, jerking spasms that at times prevented him from walking or talking.

4 Feb 2015

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients.

4 Dec 2014

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's Supplemental New Drug Application (sNDA) for its in-house-discovered AMPA receptor antagonist perampanel for the treatment of primary generalized tonic-clonic (PGTC) seizures.

20 Oct 2014

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness.

10 Sep 2014

Treatments that involve neck manipulation may be linked with strokes

Treatments that involve neck manipulation may be associated with strokes, although this association is not proven, according to an American Heart Association Scientific Statement written by lead author Dr. Jose Biller of Loyola University Medical Center and other stroke experts.

13 Aug 2014

People who suffer from MdDS now have chance for full recovery by new treatment

People who suffer from a rare illness, the Mal de Debarquement Syndrome (MdDS), now have a chance for full recovery thanks to treatment developed by researchers at the Icahn School of Medicine at Mount Sinai.

7 Aug 2014

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide.

25 Jun 2014

Neutra prepares new technology to make cannabis reliable cash crop in desert

Neutra Corp. is preparing new technology for the marketplace designed to help make cannabis a reliable cash crop—even in the desert.

5 Jun 2014

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo International plc announced today that affiliates of the company have completed the acquisition of worldwide rights to Sumavel® DosePro® (sumatriptan injection), a needle-free delivery system for subcutaneous use, from Zogenix, Inc, for $85 million in cash and rights to additional cash payments based on the achievement of certain commercial milestones.

19 May 2014

Highlights from April 2014 issue of Mayo Clinic Health Letter

Here are highlights from the April issue of Mayo Clinic Health Letter.

26 Apr 2014

Study sheds light on factors that lead to development of rare condition affecting inner ear

A new study has shed light on the factors likely to lead to the development of a rare condition affecting the inner ear.

16 Apr 2014

Neutra prepares to roll out new game-changing technology in indoor horticulture industry

As Neutra Corp. (OTCBB: NTRR) and its joint venture partner prepare to roll out a new, game-changing technology in the indoor horticulture industry, the company announced today that work has already begun on new, customizable solutions for growing operations with uncommon requirements.

10 Apr 2014

Neutra seeks new breakthroughs in greenhouse cultivation to develop and market around globe

In the company's quest to introduce new technology on the cutting edge of the indoor horticulture industry, Neutra Corp. (OTCBB: NTRR) is seeking out new breakthroughs in greenhouse cultivation to develop and market around the globe.

8 Apr 2014

New clinic that focuses on diagnosis and treatment for vertigo launched in Mumbai

In a first, a city hospital has launched a clinic dedicated to vertigo. Dr Rajeev Boudhankar, vice-president, Kohinoor Hospital, said, "We observed that vertigo is a highly under-diagnosed ailment and patients run from post to pillar looking for effective treatment.

2 Apr 2014

Vestibular system is critical for optimizing head and eye movements

Neurologists at Ludwig-Maximilians-Universitaet (LMU) in Munich have studied the role of the vestibular system, which controls balance, in optimizing how we direct our gaze. The results could lead to more effective rehabilitation of patients with vestibular or cerebellar dysfunction.

25 Mar 2014

MRI magnetic fields may diagnose, treat balance disorders and dizziness, say researchers

Expanding on earlier research, Johns Hopkins researchers report that people with balance disorders or dizziness traceable to an inner-ear disturbance show distinctive abnormal eye movements when the affected ear is exposed to the strong pull of an MRI’s magnetic field.

20 Mar 2014

Doctors receive €3.5M European Union funding to diagnose, treat balance disorders

GPs and other doctors will be equipped with a new, online information system to help diagnose and treat a range of balance disorders, thanks to €3.5m European Union funding for EMBalance.

12 Feb 2014

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals plc today announced U.S. commercial availability of Versacloz (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder.

11 Feb 2014

Vertigo News and Research

Latest Vertigo News and Research

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

23andMe announces publication of genome-wide association study of motion sickness

Whole exome sequencing helps Mayo Clinic neurologist solve a medical mystery

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

Now, women experiencing morning sickness can benefit from Diclegis drug

Treatments that involve neck manipulation may be linked with strokes

People who suffer from MdDS now have chance for full recovery by new treatment

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Neutra prepares new technology to make cannabis reliable cash crop in desert

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Highlights from April 2014 issue of Mayo Clinic Health Letter

Study sheds light on factors that lead to development of rare condition affecting inner ear

Neutra prepares to roll out new game-changing technology in indoor horticulture industry

Neutra seeks new breakthroughs in greenhouse cultivation to develop and market around globe

New clinic that focuses on diagnosis and treatment for vertigo launched in Mumbai

Vestibular system is critical for optimizing head and eye movements

MRI magnetic fields may diagnose, treat balance disorders and dizziness, say researchers

Doctors receive €3.5M European Union funding to diagnose, treat balance disorders

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vertigo News and Research

Latest Vertigo News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in